Angiogenic activity of a fusion protein of the cell-binding domain of fibronectin and basic fibroblast growth factor.

We constructed a fusion protein of the cell-binding domain of human fibronectin and human basic fibroblast growth factor, and prepared a polypeptide with both cell-adhesive activity and growth factor activity. A human gene fragment coding for basic fibroblast growth factor was amplified by the polymerase chain reaction, and introduced into the expression vector pTF7520, which encodes the cell-binding domain of human fibronectin. The resulting plasmid encoded a fusion protein in which basic fibroblast growth factor was added covalently to the C-terminal end of the fibronectin fragment. The fusion protein was expressed in Escherichia coli JM109 cells and purified from the extract by heparin affinity chromatography. The purified fusion protein had cell-adhesive activity toward BALB/c 3T3 cells, and stimulated their DNA synthesis in serum-depleted cultures. The fusion protein gave maximum mitogenic activity at the concentration of 10 nM. The fusion protein adsorbed to culture dishes, or added to collagen gels, stimulated the growth of human umbilical-vein endothelial cells. The fusion protein stimulated the angiogenesis in chorioallantoic membranes of developing chick embryos.

[1]  I. Kato,et al.  Effects of fibronectin-type V collagen recombinant fusion protein on cell adhesion and cell proliferation. , 1992, Cell structure and function.

[2]  I. Kato,et al.  Construction and characterization of a fusion protein with epidermal growth factor and the cell‐binding domain of fibronectin , 1992, FEBS letters.

[3]  S. A. Servold,et al.  Growth factor impact on wound healing. , 1991, Clinics in podiatric medicine and surgery.

[4]  K. Titani,et al.  Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. , 1991, Journal of biochemistry.

[5]  Y. Ito,et al.  Enhancement of cell growth on growth factor-immobilized polymer film. , 1991, Biomaterials.

[6]  M. Klagsbrun,et al.  The fibroblast growth factor family. , 1991, Cancer cells.

[7]  K. Sekiguchi,et al.  Role of type III homology repeats in cell adhesive function within the cell-binding domain of fibronectin. , 1991, The Journal of biological chemistry.

[8]  Y. Shimada,et al.  Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. , 1990, Biochemical and biophysical research communications.

[9]  K. Unsicker,et al.  Basic fibroblast growth factor (bFGF), a multifunctional growth factor for neuroectodermal cells , 1990, Journal of Cell Science.

[10]  K. Nishikawa,et al.  Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Titani,et al.  Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin. , 1989, Experimental cell research.

[12]  F. Hefti,et al.  Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases , 1989, Neurobiology of Aging.

[13]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[14]  S. Ho,et al.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.

[15]  P. Cuevas,et al.  Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. , 1988, Biochemical and biophysical research communications.

[16]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[17]  J. Fiddes,et al.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.

[18]  S. Szabó,et al.  A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. , 1985, Science.

[19]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[20]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[21]  T. Awata,et al.  FIBRONECTIN EYEDROPS FOR TRAUMATIC RECURRENT CORNEAL EROSION , 1983, The Lancet.

[22]  J. Folkman,et al.  Long-term culture of capillary endothelial cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[26]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[27]  K. Nishikawa,et al.  [2] Derivation of monoclonal antibody to human epidermal growth factor , 1987 .

[28]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[29]  Y. Yoshitake,et al.  DNA Synthesis-Stimulating Activities for BALB/3T3 Cells Present in Histone and Nonhistone Protein Fractions from Rat Rhodamine Fibrosarcoma , 1982 .